Literature DB >> 10364220

Structure and function of human prepro-orexin gene.

T Sakurai1, T Moriguchi, K Furuya, N Kajiwara, T Nakamura, M Yanagisawa, K Goto.   

Abstract

Orexin-A and -B are recently identified potent orexigenic peptides that are derived from the same precursor peptide and are highly specifically localized in neurons located in the lateral hypothalamic area, a region classically implicated in feeding behavior. We cloned the whole length of the human prepro-orexin gene and corresponding cDNA. The human prepro-orexin mRNA was predicted to encode a 131-residue precursor peptide (prepro-orexin). The human prepro-orexin gene consists of two exons and one intron distributed over 1432 base pairs. The 143-base pair first exon includes the 5'-untranslated region and a small part of the coding region that encodes the first seven residues of the secretory signal sequence. The second exon contains the remaining portion of the open reading frame and 3'-untranslated region. The 3.2 kilobase pairs of the 5'-upstream region from a cloned human prepro-orexin gene promoter is sufficient to direct the expression of the Escherichia coli beta-galactosidase (lacZ) gene in transgenic mice to neurons in the lateral hypothalamic area and adjacent regions. The lacZ-positive neurons were positively stained with anti-orexin antibody but not with anti-melanin-concentrating hormone antibody. These findings suggest that this genomic fragment contains all the necessary elements for appropriate expression of the gene and will be useful for the targeted expression of the exogenous gene in orexin-containing neurons. These mice might also be useful for examining the molecular mechanisms by which orexin gene expression is regulated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364220     DOI: 10.1074/jbc.274.25.17771

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Drug treatment of obesity: from past failures to future successes?

Authors:  P Collins; G Williams
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

Review 2.  Chemistry and biology of orexin signaling.

Authors:  Thomas Kodadek; Di Cai
Journal:  Mol Biosyst       Date:  2010-06-07

3.  Influence of inhibitory serotonergic inputs to orexin/hypocretin neurons on the diurnal rhythm of sleep and wakefulness.

Authors:  Sawako Tabuchi; Tomomi Tsunematsu; Thomas S Kilduff; Shouta Sugio; Ming Xu; Kenji F Tanaka; Satoru Takahashi; Makoto Tominaga; Akihiro Yamanaka
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

Review 4.  [The neurophysiology of cataplexy].

Authors:  G Mayer
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

Review 5.  K+ channels stimulated by glucose: a new energy-sensing pathway.

Authors:  Denis Burdakov
Journal:  Pflugers Arch       Date:  2007-01-06       Impact factor: 3.657

Review 6.  Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?

Authors:  Shaun Yon-Seng Khoo; Robyn Mary Brown
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

7.  Transcriptional regulation of the hypocretin/orexin gene by NR6A1.

Authors:  Susumu Tanaka; Tohru Kodama; Takashi Nonaka; Hiromi Toyoda; Makoto Arai; Miyuki Fukazawa; Yoshiko Honda; Makoto Honda; Emmanuel Mignot
Journal:  Biochem Biophys Res Commun       Date:  2010-11-05       Impact factor: 3.575

8.  The effect of clomipramine on wake/sleep and orexinergic expression in rats.

Authors:  P Feng; Y Hu; D Li; D Vurbic; H Fan; S Wang; K P Strohl
Journal:  J Psychopharmacol       Date:  2008-06-18       Impact factor: 4.153

9.  Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.

Authors:  Sawako Tabuchi; Tomomi Tsunematsu; Sarah W Black; Makoto Tominaga; Megumi Maruyama; Kazuyo Takagi; Yasuhiko Minokoshi; Takeshi Sakurai; Thomas S Kilduff; Akihiro Yamanaka
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

10.  Hypocretin/Orexin neuropeptides: participation in the control of sleep-wakefulness cycle and energy homeostasis.

Authors:  A Nuñez; M L Rodrigo-Angulo; I De Andrés; M Garzón
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.